1. Home
  2. UTHR vs DG Comparison

UTHR vs DG Comparison

Compare UTHR & DG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • DG
  • Stock Information
  • Founded
  • UTHR 1996
  • DG 1939
  • Country
  • UTHR United States
  • DG United States
  • Employees
  • UTHR N/A
  • DG N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • DG Department/Specialty Retail Stores
  • Sector
  • UTHR Health Care
  • DG Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • DG Nasdaq
  • Market Cap
  • UTHR 20.7B
  • DG 22.5B
  • IPO Year
  • UTHR 1999
  • DG N/A
  • Fundamental
  • Price
  • UTHR $448.47
  • DG $98.02
  • Analyst Decision
  • UTHR Buy
  • DG Buy
  • Analyst Count
  • UTHR 15
  • DG 25
  • Target Price
  • UTHR $459.60
  • DG $115.26
  • AVG Volume (30 Days)
  • UTHR 846.4K
  • DG 3.3M
  • Earning Date
  • UTHR 10-29-2025
  • DG 08-28-2025
  • Dividend Yield
  • UTHR N/A
  • DG 2.39%
  • EPS Growth
  • UTHR 17.94
  • DG N/A
  • EPS
  • UTHR 25.63
  • DG 5.40
  • Revenue
  • UTHR $3,077,800,000.00
  • DG $41,651,642,000.00
  • Revenue This Year
  • UTHR $13.71
  • DG $7.83
  • Revenue Next Year
  • UTHR $5.72
  • DG $4.17
  • P/E Ratio
  • UTHR $17.38
  • DG $18.27
  • Revenue Growth
  • UTHR 17.62
  • DG 4.98
  • 52 Week Low
  • UTHR $266.98
  • DG $66.43
  • 52 Week High
  • UTHR $459.48
  • DG $117.95
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 65.25
  • DG 36.41
  • Support Level
  • UTHR $415.00
  • DG $95.34
  • Resistance Level
  • UTHR $459.40
  • DG $99.23
  • Average True Range (ATR)
  • UTHR 13.47
  • DG 2.38
  • MACD
  • UTHR -1.34
  • DG -0.33
  • Stochastic Oscillator
  • UTHR 71.49
  • DG 22.33

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About DG Dollar General Corporation

With more than 20,000 locations, Dollar General's banner is nearly ubiquitous across the rural United States. Dollar General serves as a convenient shopping destination for fill-in store trips, with its value proposition most relevant to consumers in small communities with a dearth of shopping options. The retailer operates a frugal store of about 7,500 square feet and primarily offers an assortment of branded and private-label consumable items (80% of net sales) such as paper and cleaning products, packaged food, and health and beauty items at low prices. Dollar General also offers a limited assortment of seasonal merchandise, home products, and apparel. The firm sells most items at a price point of $10 or less.

Share on Social Networks: